JPWO2022131192A1 - - Google Patents

Info

Publication number
JPWO2022131192A1
JPWO2022131192A1 JP2022569971A JP2022569971A JPWO2022131192A1 JP WO2022131192 A1 JPWO2022131192 A1 JP WO2022131192A1 JP 2022569971 A JP2022569971 A JP 2022569971A JP 2022569971 A JP2022569971 A JP 2022569971A JP WO2022131192 A1 JPWO2022131192 A1 JP WO2022131192A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022569971A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022131192A1 publication Critical patent/JPWO2022131192A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022569971A 2020-12-16 2021-12-13 Pending JPWO2022131192A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020208555 2020-12-16
PCT/JP2021/045752 WO2022131192A1 (ja) 2020-12-16 2021-12-13 脳組織の炎症改善用組成物

Publications (1)

Publication Number Publication Date
JPWO2022131192A1 true JPWO2022131192A1 (ja) 2022-06-23

Family

ID=82057730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022569971A Pending JPWO2022131192A1 (ja) 2020-12-16 2021-12-13

Country Status (6)

Country Link
US (1) US20240058398A1 (ja)
EP (1) EP4265297A1 (ja)
JP (1) JPWO2022131192A1 (ja)
CN (1) CN116829164A (ja)
TW (1) TW202241477A (ja)
WO (1) WO2022131192A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114828867A (zh) * 2019-12-13 2022-07-29 株式会社明治 降低心率用组合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5076029B2 (ja) * 2010-07-30 2012-11-21 株式会社明治 メタボリックシンドローム改善効果を有する乳酸菌
PL2937424T3 (pl) * 2014-04-23 2017-09-29 National Yang-Ming University Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie
CN109069555B (zh) 2016-04-13 2022-07-26 株式会社明治 面向新生儿的用于改善脑功能的组合物
IT201600084470A1 (it) * 2016-08-10 2018-02-10 Probiotical Spa Composizione per uso nel trattamento del disturbo depressivo maggiore
CN110494551B (zh) * 2017-01-31 2023-06-16 庆熙大学校产学协力团 新型乳酸菌及其用途
KR101972236B1 (ko) * 2017-11-02 2019-04-24 서원대학교산학협력단 김치에서 분리한 락토바실러스 플란타룸 및 이의 용도
AU2018358456B2 (en) * 2017-11-02 2021-10-28 Navipharm Co, Ltd Novel lactic acid bacteria and use thereof
WO2019119261A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
CA3089187A1 (en) * 2018-02-02 2019-08-08 Kobiolabs, Inc Lactobacillus plantarum kbl396 strain and use thereof
MY184908A (en) * 2018-09-03 2021-04-30 Aqurate Ingredients Intl M Sdn Bhd Use of a probiotic metabolite for slowing signs of aging
CN111202754A (zh) * 2019-03-11 2020-05-29 江苏佰澳达生物科技有限公司 一种预防和改善老年痴呆症的益生菌组合物及其应用
CN110066753B (zh) * 2019-05-13 2020-01-07 吉林省农业科学院 植物乳杆菌dp189及其应用
JP7364390B2 (ja) * 2019-08-19 2023-10-18 株式会社明治 糖代謝改善用組成物
CN111110705A (zh) * 2019-12-27 2020-05-08 河北一然生物科技有限公司 植物乳杆菌lp45在制备改善记忆力、缓解焦虑和缓解抑郁的产品中的应用
CN111394276B (zh) * 2020-03-02 2023-04-21 上海理工大学 一种对脑卒中具有保护作用的植物乳杆菌
CN111728111B (zh) * 2020-06-28 2023-01-17 武汉康复得生物科技股份有限公司 一种缓解焦虑或抑郁的益生菌组合物及其应用
CN112386614B (zh) * 2020-11-25 2022-11-08 天津科技大学 植物乳杆菌ma2在制备预防或改善阿尔茨海默症药物或食品方面中的应用

Also Published As

Publication number Publication date
EP4265297A1 (en) 2023-10-25
WO2022131192A1 (ja) 2022-06-23
TW202241477A (zh) 2022-11-01
US20240058398A1 (en) 2024-02-22
CN116829164A (zh) 2023-09-29

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112023012656A2 (ja)
BR112021014123A2 (ja)
BR112022009896A2 (ja)
BR112023009656A2 (ja)
BR112022024743A2 (ja)
BR112023006729A2 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR102021007058A2 (ja)
BR112023008622A2 (ja)
BR102020022030A2 (ja)
BR112023011738A2 (ja)
BR112023004146A2 (ja)
BR112023011539A2 (ja)
BR112023011610A2 (ja)
BR112023008976A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016176A2 (ja)